متابعة
Dogne Jean-Michel
Dogne Jean-Michel
Professor at University of Namur
بريد إلكتروني تم التحقق منه على unamur.be
عنوان
عدد مرات الاقتباسات
عدد مرات الاقتباسات
السنة
Targeting tumor-associated carbonic anhydrase IX in cancer therapy‏
A Thiry, JM Dogne, B Masereel, CT Supuran‏
Trends in pharmacological sciences 27 (11), 566-573, 2006‏
4812006
Impact of dabigatran on a large panel of routine or specific coagulation assays‏
J Douxfils, F Mullier, S Robert, C Chatelain, B Chatelain, JM Dogné‏
Thrombosis and haemostasis 107 (05), 985-997, 2012‏
4662012
Adverse cardiovascular effects of the coxibs‏
JM Dogné, CT Supuran, D Pratico‏
Journal of medicinal chemistry 48 (7), 2251-2257, 2005‏
4362005
Standardization of pre-analytical variables in plasma microparticle determination: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop‏
R Lacroix, C Judicone, M Mooberry, M Boucekine, NS Key, ...‏
Journal of Thrombosis and Haemostasis 11 (6), 1190-1193, 2013‏
3862013
Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians‏
J Douxfils, W Ageno, CM Samama, S Lessire, H Ten Cate, P Verhamme, ...‏
Journal of Thrombosis and Haemostasis 16 (2), 209-219, 2018‏
3792018
Impact of apixaban on routine and specific coagulation assays: a practical laboratory guide‏
J Douxfils, C Chatelain, B Chatelain, JM Dogné, F Mullier‏
Thrombosis and Haemostasis 110 (08), 283-294, 2013‏
317*2013
Assessment of the impact of rivaroxaban on coagulation assays: laboratory recommendations for the monitoring of rivaroxaban and review of the literature‏
J Douxfils, F Mullier, C Loosen, C Chatelain, B Chatelain, JM Dogné‏
Thrombosis research 130 (6), 956-966, 2012‏
2902012
Carbonic anhydrase inhibitors as anticonvulsant agents‏
A Thiry, JM Dogne, CT Supuran, B Masereel‏
Current topics in medicinal chemistry 7 (9), 855-864, 2007‏
2402007
Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation‏
L Dubois, S Peeters, NG Lieuwes, N Geusens, A Thiry, S Wigfield, F Carta, ...‏
Radiotherapy and Oncology 99 (3), 424-431, 2011‏
2122011
Association between BCR-ABL tyrosine kinase inhibitors for chronic myeloid leukemia and cardiovascular events, major molecular response, and overall survival: a systematic …‏
J Douxfils, H Haguet, F Mullier, C Chatelain, C Graux, JM Dogne‏
JAMA oncology 2 (5), 625-632, 2016‏
1992016
Comparison of calibrated chromogenic anti-Xa assay and PT tests with LC-MS/MS for the therapeutic monitoring of patients treated with rivaroxaban‏
J Douxfils, A Tamigniau, B Chatelain, C Chatelain, P Wallemacq, ...‏
Thrombosis and haemostasis 110 (10), 723-731, 2013‏
1862013
Coxibs and cardiovascular side-effects: from light to shadow‏
JM Dogné, J Hanson, C Supuran, D Pratico‏
Current pharmaceutical design 12 (8), 971-975, 2006‏
1842006
Solid lipid microparticles as a sustained release system for pulmonary drug delivery‏
S Jaspart, P Bertholet, G Piel, JM Dogné, L Delattre, B Evrard‏
European journal of pharmaceutics and biopharmaceutics 65 (1), 47-56, 2007‏
1802007
Antibody titres decline 3-month post-vaccination with BNT162b2‏
J Favresse, JL Bayart, F Mullier, M Elsen, C Eucher, S Van Eeckhoudt, ...‏
Emerging microbes & infections 10 (1), 1495-1498, 2021‏
1632021
Anticonvulsant sulfonamides/sulfamates/sulfamides with carbonic anhydrase inhibitory activity: drug design and mechanism of action‏
A Thiry, JM Dogne, CT Supuran, B Masereel‏
Current pharmaceutical design 14 (7), 661-671, 2008‏
1512008
Comparison of calibrated dilute thrombin time and aPTT tests with LC-MS/MS for the therapeutic monitoring of patients treated with dabigatran etexilate‏
J Douxfils, JM Dogné, F Mullier, B Chatelain, Y Rönquist-Nii, ...‏
Thrombosis and haemostasis 110 (09), 543-549, 2013‏
1432013
Ir-CPI, a coagulation contact phase inhibitor from the tick Ixodes ricinus, inhibits thrombus formation without impairing hemostasis‏
Y Decrem, G Rath, V Blasioli, P Cauchie, S Robert, J Beaufays, JM Frère, ...‏
Journal of Experimental Medicine 206 (11), 2381-2395, 2009‏
1392009
Thromboxane, prostacyclin and isoprostanes: therapeutic targets in atherogenesis‏
JM Dogné, J Hanson, D Pratico‏
Trends in pharmacological sciences 26 (12), 639-644, 2005‏
1372005
Pathophysiology, diagnosis, and treatment of paroxysmal nocturnal hemoglobinuria: a review‏
B Devalet, F Mullier, B Chatelain, JM Dogné, C Chatelain‏
European journal of haematology 95 (3), 190-198, 2015‏
1332015
Prostanoids as pharmacological targets in COPD and asthma‏
S Rolin, B Masereel, JM Dogné‏
European journal of pharmacology 533 (1-3), 89-100, 2006‏
1262006
يتعذر على النظام إجراء العملية في الوقت الحالي. عاود المحاولة لاحقًا.
مقالات 1–20